Summary
Advanced Accelerator Applications S.A. (AAA) is a radiopharmaceutical company that develops, produces and markets molecular nuclear medicine diagnostic and therapeutic products. The company’s lead product candidate includes Lutathera, a lutetium-177 somatostatin analogue peptide that is used for the treatment of midgut neuroendocrine tumors. It provides positron emission tomography (PET) and single photon emission computed tomography (SPECT) products. AAA caters its products for diagnosis in clinical cardiology, oncology, neurology, and infectious and inflammatory diseases. It operates in France, Italy, the UK, Germany, Switzerland, Spain, Poland, Portugal, Israel, the US, and Canada among others. AAA is headquartered in Saint Genis Pouilly, France.
Advanced Accelerator Applications S.A. (AAAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Advanced Accelerator Applications S.A., Medical Devices Deals, 2010 to YTD 2016 9
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Advanced Accelerator Acquires Rights To Fabovar From Dompe 12
Venture Financing 14
Advanced Accelerator Applications Raises USD26 Million in Venture Financing 14
Advanced Accelerator Applications Raises US$56 Million In Venture Financing 15
Advanced Accelerator Raises US$6 Million In First Tranche Of Venture Financing 16
Advanced Accelerator Secures US$57 Million In Venture Financing 17
Partnerships 18
Vect-Horus Enters into Collaboration Agreement with Advanced Accelerator Applications for Radio-Imaging Agents 18
Advanced Accelerator Applications Forms Joint Venture With Institut Curie 19
Licensing Agreements 20
Advanced Accelerator Applications Enters into Licensing Agreement with Johns Hopkins University 20
Equity Offering 21
Advanced Accelerator Applications to Raise up to USD80 Million in IPO 21
Acquisition 23
Advanced Accelerator Applications Acquires IDB Group 23
Advanced Accelerator Applications Acquires Remaining 49.9% Stake in Atreus Pharma 24
Atreus Pharma Secures US$6 Million From Advanced Accelerator Applications 25
Advanced Accelerator Applications S.A. - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List Of Tables
List of Tables
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Advanced Accelerator Applications S.A., Deals By Therapy Area, 2010 to YTD 2016 8
Advanced Accelerator Applications S.A., Medical Devices Deals, 2010 to YTD 2016 9
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Advanced Accelerator Acquires Rights To Fabovar From Dompe 12
Advanced Accelerator Applications Raises USD26 Million in Venture Financing 14
Advanced Accelerator Applications Raises US$56 Million In Venture Financing 15
Advanced Accelerator Raises US$6 Million In First Tranche Of Venture Financing 16
Advanced Accelerator Secures US$57 Million In Venture Financing 17
Vect-Horus Enters into Collaboration Agreement with Advanced Accelerator Applications for Radio-Imaging Agents 18
Advanced Accelerator Applications Forms Joint Venture With Institut Curie 19
Advanced Accelerator Applications Enters into Licensing Agreement with Johns Hopkins University 20
Advanced Accelerator Applications to Raise up to USD80 Million in IPO 21
Advanced Accelerator Applications Acquires IDB Group 23
Advanced Accelerator Applications Acquires Remaining 49.9% Stake in Atreus Pharma 24
Atreus Pharma Secures US$6 Million From Advanced Accelerator Applications 25
Advanced Accelerator Applications S.A., Key Competitors 26
Advanced Accelerator Applications S.A., Key Employees 27
Advanced Accelerator Applications S.A., Subsidiaries 28
Lisst Of Figures
List of Figures
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Advanced Accelerator Applications S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Advanced Accelerator Applications S.A., Medical Devices Deals, 2010 to YTD 2016 9
